Do HDL particles remove cholesterol from peripheral tissues and deliver it to the liver for excretion?

The biological model of reverse cholesterol transport (RCT) defines high-density lipoprotein (HDL) as a vital vehicle for maintaining lipid homeostasis. This pathway facilitates the movement of excess cholesterol from peripheral tissues—including arterial macrophages—to the liver for final elimination.

Clinical and effectiveness evidence

While clinical focus has historically been on static HDL-C levels, recent evidence emphasizes that HDL "functionality" is the primary driver of cardiovascular protection.

• Cholesterol Efflux Capacity (CEC): The initial step of RCT, where HDL accepts cholesterol from cells, is a potent predictor of cardiovascular health. In the Dallas Heart Study (n=2,099), participants with the highest CEC had a 67% lower risk of major cardiovascular events (HR 0.33; 95% CI, 0.17-0.63) compared to those with the lowest, regardless of their total HDL cholesterol levels.
• Flux vs. Concentration: Research into CETP inhibitors has demonstrated that simply increasing the concentration of HDL particles does not always translate to better outcomes. The effectiveness of the RCT pathway depends on the continuous "flux"—the rate at which cholesterol is actively moved through the system—rather than the amount of HDL measured in a standard blood panel.

Mechanistic explanations

The RCT pathway is a sophisticated three-step process involving specific molecular transporters and receptors.

• Cholesterol Acceptance (Efflux): Lipid-poor apolipoprotein A-I (apoA-I) interacts with the ATP-binding cassette transporter A1 (ABCA1) on peripheral cells to acquire free cholesterol. Mature HDL particles further expand this pool by accepting cholesterol via the ABCG1 transporter and Scavenger Receptor Class B Type I (SR-BI).
• Hepatic Delivery: Once cholesterol is esterified within the HDL core, it is delivered to the liver. This occurs either directly through SR-BI-mediated selective uptake—where the liver "skims" the cholesterol without destroying the HDL particle—or indirectly via Cholesteryl Ester Transfer Protein (CETP), which transfers the cargo to LDL particles for hepatic clearance.
• Biliary Excretion: In the final stage, the liver processes this cholesterol for excretion. It is either converted into bile acids or secreted directly as free cholesterol into the bile via the ABCG5 and ABCG8 transporters, eventually leading to elimination from the body.

Bottom line

The claim is strongly supported by scientific evidence. HDL particles serve as the essential mediators of reverse cholesterol transport, effectively removing cholesterol from the periphery and delivering it to the liver. For clinical practice, this highlights that the functional ability of HDL to move cholesterol (efflux capacity) is a more critical health indicator than the absolute quantity of HDL-C.